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Sourdough is a very complex biological system, which obtained from 
water and cereal fermentation. Sourdough fermentation usually consists of 
combinations of probiotic lactobacilli starters and prebiotic dietary fibers 
called synbiotics which have a synergistic effect, greater than that of either 
the probiotic or prebiotic administered individually. Preliminary research 
suggests that synbiotics offer anti-cancer benefits to the human body. The 
risk of lung, colon, liver, breast and bladder cancer may be reduced with 
the help of synbiotic effects. The most promising research is the ability of 
synbiotics to improve the health of cancer patients undergoing radiation 
therapy. Proposed mechanisms of action of probiotics lactobacilli starters 
and prebiotics dietary fibers in cancer include binding of carcinogens, 
alteration in gut microbiota formation and metabolism of carcinogens, 
stimulation suppression of carcinogenesis, improvement in epithelial 
barrier function, anti-inflammatory effects, inductance of apoptosis, and 
inductance of protective enzymes. Briefly these mechanisms and 
synbiotics effect of fiber-rich sourdough fermentation in cancer prevention 
will be discussed in this mini review. 
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Cancer is the main lead-in cause of death in highly-
developed countries and over the past decade it has 
become clear that nutrition plays a major role in cancer 
prevention. The fact that incidence has been rising in 
parallel with economic development indicates that 
environmental factors such as diet might play a role in 
the causation of cancer. It has been evaluated by the 
world cancer research fund that 30 to 40% of all 
cancers can be prevented by diet and proper body 
weight management. Prevention of cancer remain also 
the most promising strategy for reducing its incidence 
of this disease. For more than ten years, findings from 
basic research and clinical trials have informed the 
development of proper lifestyle and medical 
approaches to cancer prevention (1).  
Data have pointed to nutrition as one of the most 
relevant external factors involved in cancer 
prevention. There is no need to adopt a foreign 
dietary scheme in order to protect oneself against 
cancer. Traditional western diets also have their good 
factors that should be regular constituents in our 
foods. Lignans from traditionally made sourdough 
rye bread, linseed/flaxseed and berries are sources of 
potentially cancer protective factors.  
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Furthermore, indole-3-carbinol rich cabbage species can contribute to 
cancer protective covering, too. But, clear cut recommendations for 
single nutrients or secondary plant metabolites are not yet possible, 
lacking sufficient data on individual bioavailability, safety and long term 
outcome. Cancer prevention by dietary means therefore relies on an 
individually tailored mixed diet, rich in basic meals and traditional 
manufacturing and preparation methods (2).  Nowadays, there is growing 
producer interest in health aspects of food, including functional and 
synbiotic food products with specific physiological functions of health 
relevance.  
 
The term synbiotic has been proposed for combinations of prebiotic 
ingredients and probiotic microorganisms that beneficially affect the host by 
improving the survival and implantation of live microbial dietary 
supplements in the gastrointestinal tract, by selectively stimulating the 
growth and activating the metabolism of one or a limited number of health-
promoting microorganisms, and thus improving host welfare. The probiotic 
originates from the ancient Greek words pro and biotica, meaning “for life” 
and the most acceptable definition of a probiotic is a living microorganism 
which upon ingestion in certain numbers, exert health benefits beyond 
inherent general nutrition. A probiotic should be non-pathogenic, non-toxic 
and also resistant to low pH and bile salts to improve its survival in the 
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Most probiotics are members of two genera of lactic acid bacteria (LAB), Lactobacillus and Bifidobacterium. 
A prebiotic is a non-digestible food ingredient that beneficially affects the host by selectively stimulating the 
growth and activity of one or a limited number of microorganisms in the colon that have the potential to 
improve host health. A number of poorly digested carbohydrates fall into the category of prebiotics, 
including certain fibers and resistant starches, but the most widely described prebiotics are non-digestible 
oligosaccharides and microbial exopolysaccharides. Combinations of probiotic microorganisms and prebiotic 
ingredients (synbiotics) can result in additive or synergistic effects on gastrointestinal function (3). 
The definition for probiotic microorganisms has gradually changed with increasing understanding of the 
mechanisms by which they influence human life. Health effects related to changes in the intestinal microflora 
also related to adhesion and immune system effects, competitive exclusion or metabolic and 
nutritional effects, with an increasing array of other potential modes of action. Most clinically 
documented and validated health effects have been investigated using either fermented milks 
containing viable pure cultures. Specific targets for the future include controlled studies comparing 
foods containing viable strains to those containing non-viable strains and to assess the combined 
effects of multiple probiotic microorganisms(4). 
Certain probiotic interventions have shown promise in selected clinical 
conditions where aberrant microbiota have been reported, such as dermatitis, 
enterocolitis, pouchitis and possibly irritable bowel syndrome. However, no 
studies have been conducted that can causally link clinical improvements to 
changes of probiotic-induced microbiota. Whether a pattern of disease-prone 
microbiota can be remodelled to a more robust, resilient and disease-free state 
by probiotic administration remains a key unanswered question. Progress in 
this area will be facilitated by optimising strain, dose and product 
formulations, including protective commensal species, matching these 
formulations with selectively responsive subpopulations and identifying ways 
to manipulate diet to modify microbial profiles and metabolism (5). 
The prebiotic ingredients and probiotic microorganisms area is a fast evolving 
field that attracts significant interest by both the industrial and academic 
communities. Therefore, many researches are generated every year. The target 
of many probiotics and prebiotics is the prevention and treatment of disorders 
associated with the gastrointestinal tract and suggested as therapeutic 
materials. An increasing amount of evidence from in vitro and in vivo 
researches suggests that they are effective in the prevention of allergies and 
may have potential anti-carcinogenic effects. In addition to the above, there 
has been considerable interest in extra-intestinal application of probiotic 
microorganisms and prebiotic ingredients, such as in urogenital infections and 
oral health. Because factors involved in the initiation and promotion of cancer 
might be separated in time from actual tumor development, it is difficult to 
choose outcomes or end points that are definitive indicators of efficacy of 
probiotic starters or prebiotic materials. Studies that have showed the cause-
effect relationship directly have used usually animal models (6, 7). 
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Current cancer treatments including chemotherapy, radiotherapy and surgery are all associated with a high 
risk of complications and are not always successful, highlighting the need to develop new treatment ways. 
The ingestion of synbiotics represents a novel new therapeutic option. Probiotics and prebiotics act to alter the 
intestinal microflora by increasing concentrations of beneficial microorganisms, and reducing the levels of 
pathogenic agents. This strategy has the potential to inhibit the development and progression of neoplasia via 
mechanisms including decreased intestinal inflammation, enhanced immune function and anti-tumorigenic 
activity, binding to potential food carcinogens such as toxins found in some food products, and a reduction in 
microbial enzymes which hydrolyse pre-carcinogenic compounds. There is substantial experimental evidence 
to suggest that probiotic starters and prebiotic ingredients may be beneficial in the cancer prevention and 
treatment, however to date there have been few conclusive human trials (8).  
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Sadeghi et al, 2015 
Running Title: Cancer Prevention by Synbiotics Effect... 
Vol 1, Issue 1, Oct., 2015, p:26-38 
Epidemiological studies have shown that regular consumption of 
meals based on whole-grain cereals and their products is associated 
with reduced risks of various types of degenerative chronic diseas-
es. Food proteins are considered an important source of nutraceuti-
cal peptides and amino acids that can exert biological functions to 
promote health and prevent different disease and cancers. There are 
several reports on peptides with anti-tumour activity. Plant-derived 
peptides, such as lunasin have received main attention (9). Intake of 
whole grain foods is increasingly reported to be associated with 
health benefits, including improved regulation of blood glucose 
levels, decreased risk of diabetes, cardiovascular disease, and cer-
tain cancers. Sourdough fermentation has also proven useful in im-
proving the texture and palatability of whole grain and fiber-rich 
products, and it may stabilise or increase the levels of bioactive 
compounds. The production of prebiotic compounds by LAB also 
is an interesting possibility (10).  
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Furthermore, there is several health or nutritional benefits possible from 
some species of LAB such as improved nutritional value and digestion of 
lactose, control of intestinal infections, some types of cancer and serum 
cholesterol levels. Some potential benefits may result from growth and 
action of the probiotic bacteria during the manufacture of cultured foods. 
Some may result from growth and action of certain species of the probiotic 
LAB in the intestinal tract following ingestion of foods containing these 
microorganisms. In selecting a culture for specific benefit it is necessary to 
consider not only the wide variation among species of the LAB but also 
that among strains within a given species (11). LAB are a diverse group of 
bacteria that produce lactic acid as their major fermented product and most 
of them are normal flora of human being and produce myriad beneficial 
effects for human including alleviation of lactose intolerance, diarrhea, 
peptic ulcer, stimulation of immune system, antiallergic effects, antifungal 
actions, preservation of food and prevention of colon cancer (12). While a 
myriad of healthful effects have been attributed to the probiotic LAB, per-
haps the most controversial remains that of anticancer and anti-
carcinogenic activity (13). 
Fermented cereal foods are an essential component of the daily diet. Nutri-
tionally, they are an important source of carbohydrates, protein, dietary 
fiber, many vitamins and components not essential for growth but with 
potential biological functions. Recent findings have indicated a protective  
References 
 
11. Gilliland SE. Health and 
nutritional benefits 
from lactic acid bacte-
ria. FEMS Microbiol 
Rev. 1990 1990/09//;7
(1-2):175-88. 
12. Masood MI, Qadir MI, Shi-
razi JH, Khan IU. Bene-
ficial effects of lactic 
acid bacteria on human 
beings. Crit Rev Micro-
biol. 2011 2011/02//;37
(1):91-8. DOI: 
10.3109/1040841x.201
0.536522. 
13. Rafter J. Lactic acid bacteria 
and cancer: mechanistic 
perspective. Br J Nutr. 
2002 2002/09//;88 
Suppl 1:S89-94. DOI: 
10.1079/bjn2002633. 
 
Running Title: Cancer Prevention by Synbiotics Effect... 
Vol 1, Issue 1, Oct., 2015, p:26-38 
www.thecancerpress.com 
Sadeghi et al, 2015 
role of especially fermented whole grain foods against several 
Western diseases (14, 15). Dietary fiber was long considered the 
major health protective component of these grains. There is now 
increasing evidence also of other protective compounds, such as 
oligosaccharides, phytochemicals and bioactive peptides which 
together with dietary fiber are concentrated in The levels and also 
bioavailability of carbohydrates and various bioactive compounds 
(compounds effecting human physiological reactions with health 
relevance) can remarkably be influenced by food processing chain (16). 
Sourdough fermentation especially in whole cereal grains is one of the 
oldest food biotechnologies, which has been studied and rediscovered for 
its effect on the sensory, structural, functional, nutritional and shelf life 
properties of leavened baked goods. Acidification, proteolysis and 
activation of some enzymes as well as the synthesis of microbial 
metabolites cause several changes during this fermentation, which affect 
the dough and baked product matrix and influence its functional quality 
(17). A common trend of sourdough fermentations is the unique symbiosis 
of certain hetero and homo fermentative probiotic LAB with certain 
yeasts. The most relevant bacteria isolated from different sourdoughs 
belong to the genus Lactobacillus. Some of the reported benefits of 
sourdough on quality of final product may be based on the formation of 
exopolysaccharides by certain probiotic LAB, whereas most of the 
beneficial properties attributed to sourdough are determined by the 
acidification activity of these microorganisms (18).  
In principle, the whole grain or fractions of cereal grain can be modified 
by LAB sourdough fermentation to improve nutritional value or promote 
healthiness of cereal foods. Whole meal flour is rich in fiber, minerals, 
vitamins and many phytochemicals or bioactive compounds such as 
phenolic compounds, sterols, tocopherols, tocotrienols, lignans and phytic 
acid. However, whole meal products are not always in the market, because 
of the lack of palatable taste and appealing mouth feel. With LAB 
sourdough processes the mouth feel and palatability of whole meal cereals 
can be improved without removing any nutritionally important 
components. Sourdough fermentation also improves texture and flavour of 
bran-rich products (19). 
The changes during LAB sourdough fermentation in cereal products 
potentially leading to improved nutritional quality are numerous. These 
are including acid production, suggested to retard starch digestibility and 
to adjust pH to a range which favours the action of certain endogenous  
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enzymes, thus changing the bioavailability pattern of minerals and bioactive 
compounds. This is especially beneficial in rich bran products to deliver minerals and 
potentially protective compounds in the blood system.   
The action of enzymes during LAB sourdough fermentation also causes hydrolysis 
and solubilisation of grain macromolecules, such as proteins and cell wall 
polysaccharides. This changes product structure, which may affect nutrient and non-
nutrient absorption. New bioactive compounds, such as prebiotic exopolysaccharides 
or other metabolites, may also be formed in cereal fermentations by LAB sourdough 
(10, 20).  
Recently the potential of sourdough LAB to release lunasin as an anti-tumour peptide 
during fermentation of cereal and nonconventional flours was investigated by (21). 
The peptidase activities of a large number of sourdough LAB were analyzed using 
synthetic substrates. Selected probiotic LAB were used as sourdough starters to 
ferment whole meal wheat, soybean, barley, amaranth, and rye flours. Proteinase 
activity during sourdough fermentation was characterized and after fermentation, 
lunasin from the water-soluble extracts was quantified and purified. Compared to 
control doughs, the concentration of lunasin increased up to 2–4 times during 
sourdough fermentation. Lactobacillus curvatus SAL33 and Lactobacillus brevis 
AM7 synthesized the highest concentrations of lunasin in all the flours. Besides the 
presence of the entire lunasin sequence, fragments containing the immunoreactive 
epitope were also determined. This study showed that fermentation by sourdough 
LAB increased the concentration of lunasin to levels that would suggest new 
possibilities for the biological synthesis and for the formulation of functional foods. 
Dietary interventions for preventing cancer have recently attracted increased attention 
from researchers and clinicians. The probiotic microorganisms have emerged as 
potential therapeutic agents but are also regarded as healthy dietary supplements for 
functional and health applications. The metabolome of probiotic may interfere with 
various cellular and molecular processes, including the onset and progression of colon 
cancer. The metabolites of probiotic bacteria may lead to the modulation of diverse 
cellular signal transduction and metabolic pathways. The gut microbial metabolites 
such as organic acids, bacteriocins and other peptides have been noted to interact with 
multiple key targets in various metabolic pathways that regulate cellular proliferation, 
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 Progress in this field suggests that epigenetic alterations will be 
widely used in the near future to cancer prevention and treatment (22).  
Fiber-rich sourdough fermentation usually consists of synbiotic 
combinations of probiotic lactobacilli starters and prebiotic dietary 
fibers. The precise mechanisms by which this synbiotic effect may 
inhibit cancer might include alteration of the metabolic activities of 
intestinal microflora and physicochemical conditions in the colon, 
binding and degrading potential carcinogens, alterations in the 
intestinal microflora incriminated in producing putative carcinogens 
and promoters production of anti-tumourigenic or anti-mutagenic 
compounds, enhancing the host's immune response and effects on 
physiology of the host. The mechanisms of these abilities have been 
discussed briefly in next paragraphs  
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Main Mechanisms by Which Synbiotic Fermentation May  
Inhibit Cancer 
Considering the increasing incidence of cancer disease, the last decade has seen much attention directed 
towards understanding possible prevention and treatment strategies. Efforts to study the intestinal microbiota 
and its interaction with the host have underlined that disbiosis in colonic microbial composition is a risk 
factor for colon cancer. Modulation of the composition of intestinal microorganisms through the use of 
probiotic, prebiotic and synbiotic products could therefore represent a strategy for prevention of cancer 
development. Wide spectrum impact of probiotic bacteria and prebiotic compounds on the host health has 
been proved. These microorganisms have been confirmed to boost immunity, aid in digestion, eliminate 
pathogens, inflammatory bowel diseases, moderate side effects of antibiotic therapy, lower cholesterol and 
blood glycemic index and produce vitamins. Researchers are in universal agreement with the critical role of 
probiotic LAB in getting rid of mutagens, delaying the onset of tumors, alleviating the side effects, pepping 
up chemotherapy, easing the postoperative complications, foiling remission and lifting the spirit of survivors 
(23). anti-mutagenic ingredients and short chain fatty acids, binding of mutagens, suppression of bacteria 
that convert pro-carcinogens into carcinogens, immune system stimulation, elevating the hosts’ immune 
response and altering the hosts’ physiology and reduction in level certain intestinal bacterial enzymes that 
promote carcinogen formation (24, 25). 
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The reported anti-cancer mechanisms of probiotic bacteria encompass intraluminal, systemic, and direct effects 
on intestinal mucosa. Intraluminal effects include competitive exclusion of pathogenic intestinal microflora, 
alteration of intestinal microbial enzyme activity, reduction of carcinogenic secondary bile acids, binding of 
carcinogens and mutagens, and increasing short chain fatty acids production. Reduction of DNA damage and 
suppression of aberrant crypt foci formation have been well demonstrated as direct anti-cancer effects of probi-
otic microorganisms on intestinal mucosa. Existing evidence clearly support a multifaceted immuno modulatory 
role of probiotic LAB in cancer, particularly its ability to modulate intestinal inflammation, a well known risk 
factor for cancer. The effectiveness of probiotic bacteria in cancer prevention is dependent on the strain of the 
microorganism, while as indicated by several studies, viability may not be a prerequisite for certain probiotic 
anticancer mechanisms. Emerging data suggest synbiotic as a more effective approach than either prebiotic mi-
croorganisms or probiotic compounds alone. More in vivo especially human studies are warranted to further 
elucidate and confirm the potential role of viable and non-viable probiotics, prebiotics and synbiotics in cancer 
prevention (26). 
Probiotic LAB appear to have three general ways to fight cancer. First, certain strains of probiotics can elimi-
nate substrates that can be turned into carcinogens and promote the development of cancer. Such a substance is 
called a pro-carcinogen and an example of pro-carcinogen is nitrite that is unstable compound or ion. Probiotics 
in the intestinal tract convert pro-carcinogens like nitrites into neutral ingredients. Lactobacillus acidophilus is 
an example of a probiotic strain that can neutralize these problem substrates in our body. Other species may also 
have this ability. Second, probiotic LAB can stop enzymes which help turn pro carcinogens into carcinogens. 
These enzymes are secreted by undesirable bacteria, such as Clostridium and Bacteriodes, which are normally 
found in our gut and particularly live in our lower intestine. With fewer enzymes to create cancer-causing chem-
icals, the body is less likely to develop cancer disease. Lactobacillus acidophilus is particularly effective at neu-
tralizing harmful enzymes that promote cancer expansion. This may be the most important contribution of pro-
biotic LAB to cancer prevention .The third way probiotic bacteria appear to have anti-cancer effects in the body 
is less direct. . We already know there is a positive interaction between probiotic LAB and our immune system. 
Probiotic bacteria support and stimulate the immune system in many positive ways. However, probiotic LAB 
also help the immune system by lightening its load. Probiotic bacteria promote a healthy intestinal lining. This 
reduces the ability of undesirable microorganisms that we eat from entering into our bloodstream.  
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With fewer undesirable microbes in our blood that our immune system has to trap 
and eliminate, the less work it has to do. Thus, our immune system can focus on its 
main role and helping cells that are damaged and prevent these cells from becoming 
cancer. In general, healthy colonies of probiotic bacteria in the intestinal tract can 
support the immune system, leaving it more energy and resources to focus on cancer 
prevention. Probiotic LAB by their properties may help strengthen homeostasis and 
thus reduce side effects associated with cancer treatment. Experimental evidence 
suggests that probiotic microorganisms might have also beneficial effect on the 
toxicity of anticancer therapy (27). 
 
The relationship between cancer, diet, and gut microflora is very complex. The 
substrates entering the colon from the ileum and the resident microbiota represent 
key determinants of colon physiology. The ability of the colonic microorganisms to 
generate a wide variety of mutagens, carcinogens and tumor promoters from dietary 
precursors is well documented. A major role for the intestinal bacteria has been 
identified in the metabolism of some bile acids, which are thought to possess tumor-
promoting activity. Other potential tumor-promoters are also generated by 
deamination of some amino acids by these bacteria (28). 
 
There are a large number of reports describing the adsorption or binding in vitro by 
probiotic LAB and other intestinal bacteria, of a variety of food-borne carcinogens 
including the heterocyclic amines formed during cooking of food, Aflatoxin B1, 
benzopyrene and some food contaminants. In several of these researches, a 
concomitant decrease in mutagenicity was reported. The extent of the binding was 
dependent on the mutagen and bacterial strain used usually greatest binding was 
seen with the heterocyclic amines and least with Aflatoxin B1.  
 
The adsorption appeared to be a physical phenomenon, but binding represents a 
plausible mechanism for the inhibition of genotoxicity and mutagenicity by 
probiotic LAB in vitro, it does not appear to have any influence in vivo (29). 
In general, species of Bifidobacterium and Lactobacillus, have low activities of 
enzymes involved in carcinogen formation and metabolism by comparison to other 
major anaerobe bacteria in the gut such as bacteroides, eubacteria and clostridia.   
This suggests that increasing the proportion of probiotic LAB in the gut could 
modify, beneficially, the levels of xenobiotic metabolizing enzymes. Studies have 
been carried out in laboratory organisms in order to acquire a greater understanding 
of the way in which administration of specific probiotic bacteria and prebiotic 
compounds affect gut microbiota metabolism (30) 
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 Studies demonstrate that the increase in concentration of probiotic LAB as a 
consequence of consumption of these bacteria leads to decreases in certain 
bacterial enzymes purported to be involved in synthesis or activation of 
carcinogens, genotoxins and tumor promoters. This would appear to be due to 
the low specific activity of these enzymes in probiotic LAB. Such changes in 
enzyme activity or metabolite concentration have been suggested to be 
responsible for the decreased level of preneoplastic lesions or tumors seen in 
carcinogen-treated rats given probiotic bacteria and prebiotic ingredient. 
Although a causal link has not been demonstrated, this remains a plausible 
hypothesis. There is considerable focus currently on synbiotics, the theory being 
that, the metabolites of the fermentation of the prebiotic compounds by the 
probiotic bacteria will have anti-cancer activity. Anti-inflammatory effects have 
been also reported for some probiotic LAB. For example, Borruel et al. (33) 
observed decreases in cancer cells in human ileal specimens obtained from 
patients with Crohn’s disease and treated ex vivo with Lactobacillus casei 
DN114001 and Lactobacillus bulgaricus LB10. The establishment of oral 
tolerance within the host in the long term may mean that modulation of host 
immunity is a temporary event, confined to early intake of probiotic bacteria.  
However, in the rat the inhibition of carcinogenesis correlates with changes to 
immune activity in response to consumption of probiotic LAB (34). Further 
work is needed to assess the long term effects of probiotic microorganisms on 
host immunity in relation to anti-carcinogenesis. The human probiotic 
Propionibacterium freudenreichii kills colorectal adenocarcinoma cells through 
apoptosis in vitro via its metabolites, the short chain fatty acids (SCFA). In 
general, the precise mechanisms, the kinetics of cellular events and the impact 
of environmental factors such as pH remained to be specified. Investigations 
demonstrate a major impact of a shift in extracellular pH on the mode of 
propionibacterial SCFA-induced cell death of cancer cells, in the pH range 5.5 
to 7.5 prevailing within the colon. Propionibacterial SCFA triggered apoptosis 
in the pH range 6.0 to 7.5, a lethal process lasting more than 96 h. Indeed at pH 
7.5, SCFA induced cell cycle, followed by a sequence of cellular events 
characteristic of apoptosis. By contrast, at pH 5.5, the same SCFA triggered a 
more rapid and drastic lethal process in less than 24 h.  This was characterised 
by sudden mitochondrial depolarisation, inner membrane permeabilisation and 
drastic depletion in ATP levels, suggesting death by necrosis. Thus, in digestive 
cancer prophylaxis, the observed pH-mediated switch between apoptosis and 
necrosis has to be taken into account in strategies  involving SCFA  production 
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by propionibacteria to kill colon cancer cells (35). 
 
The most recent data generated by studies in clinical trials on the role of 
probiotic LAB in preventing colorectal cancer and the mechanisms pro-
posed have been reviewed (36). Reduction of colonic carcinogenesis has 
been attributed to controlling colorectal neoplastic progression via an in-
creased proportion of probiotic bacteria with proinflammatory characteris-
tics. Studies in humans have examined the effect of oral administration of 
yogurt supplemented with probiotic LAB on intestinal microbiota associat-
ed with colorectal cancer. A significant decrease in these cells was reported 
in the probiotic treatment group but not in the milk control group, implying 
the potential of probiotic bacteria for eliminating microorganisms associat-
ed with colorectal An intervention study undertaken in the pouches of pa-
tients with familial adenomatous polyposis showed decreased cell prolifera-
tion and increased detoxification capacity after treatment with probiotic 
LAB and prebiotics such as inulin. This mechanism and others were 
demonstrated experimentally in animals using a rat colon cancer model to 
examine DNA damage and colorectal tumorigenesis. In the future, with 
growing understanding of the human microbiome, probiotic LAB may serve 
as chemoprotective agents for the prevention of cancer.  
 
However, more clinical trials in humans are needed to assess probiotics pro-
tective effect. A number of studies have been carried out on the effects of 
probiotics, prebiotics and synbiotics on human subjects which have includ-
ed measurement of bacterial enzyme activities. Effects in human researches 
of prebiotic LAB and synbiotics on toxic bacterial metabolites in feces are 
few and generally have yielded inconsistent or negative results. More direct 
evidence for protective properties of probiotic bacteria and prebiotic ingre-
dients against cancer has been obtained by assessing the ability of cultures 
to prevent DNA damage and mutations as an early event in the process of 
carcinogenesis in cell cultures or in organisms. Using the technique of sin-
gle cell microgel electrophoresis, (37) investigated the ability of a range of 
species of probiotic LAB to inhibit DNA damage in the colon. mucosa of 
rats treated with the carcinogens. Klinder et al. (38)  also showed that 
prebiotic and synbiotic supplementation (8 months) caused a reduction in 
the genotoxicity of fecal and cecal samples obtained from azoxymethane. 
Rafter et al. (39) evaluated the influence of 12 weeks synbiotic supplemen-
tation  of probiotic Lactobacillus rhamnosus GG and probiotic Bifidobacte-
rium lactis Bb12 with a commercial fructan as a prebiotic compound on 
selected cancer biomarkers in polypectomized and cancer patients. 
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Synbiotic supplementation resulted in significant reductions in DNA 
damage in the colonic mucosa of polyp patients. The above results pro-
vide evidence that both probiotic LAB and prebiotics may have protec-
tive effects against the early stages of colon cancer. There are fewer re-
ports on prebiotic and synbiotics than on probiotics in terms of tumor 
incidence but overall the studies indicate protective effects. 
Jacobson et al (40) compared the incidence of tumors in challenged rats 
following consumption of FOS or inulin as prebiotics. Significantly less 
rats developed colon tumors in the FOS group compared to the control 
diet. The total number of tumors developed per rat was significantly re-
duced following both prebiotic FOS and inulin supplementation, but sup-
plementation had no effect on the malignancy of the tumors. Femia et al. 
(41) investigated the protective effects of prebiotic ingredients, probiotic 
Bifidobacterium lactis Bb12 and Lactobacillus rhamnosus GG, or synbi-
otic combination of the two, against induced colon tumors in rats. Prebi-
otic and synbiotic fed groups resulted in lower adenoma and adenocarci-
noma incidence than in the rats not given prebiotic (probiotic and con-
trol). Prebiotic and synbiotic groups had in fact nine cancers over 84 tu-
mors (11%), while controls and probiotic groups had 19 cancers over 83 
tumors (23%). the number of rats with induced colon tumors, as well as 
the number of tumors per rat. Amer et al., isolated novel lactobacilli pro-
biotic strains from human feces and screen them for the presence of two 
valuable antitumor genes for future potential therapeutic application in 
cancer prevention. (42). Prevention of febrile neutropenia by probiotic 
Enterococcus faecium M-74 enriched with selenium in leukemic patients 
was also studied by Mego et al., (43). Febrile neutropenia remains a po-
tentially life-threatening complication of anticancer chemotherapy.  
References: 
 
40. Jacobsen H, Poulsen M, Drag-
sted LO, Ravn-Haren G, Mey-
er O, Lindecrona RH. Carbo-
hydrate digestibility predicts 
colon carcinogenesis in 
azoxymethane-treated rats. 
Nutr Cancer. 2006 2006;55
(2):163-70. DOI: 10.1207/
s15327914nc5502_7. 
41. Femia AP, Luceri C, Dolara P, 
Giannini A, Biggeri A, Salva-
dori M, Clune Y, Collins KJ, 
Paglierani M, Caderni G. Anti-
tumorigenic activity of the 
prebiotic inulin enriched with 
oligofructose in combination 
with the probiotics Lactobacil-
lus rhamnosus and Bifidobac-
terium lactis on azoxymethane-
induced colon carcinogenesis 
in rats. Carcinogenesis. 2002 
2002/11//;23(11):1953-60. 
42. Amer MN, Mansour NM, El-
Diwany AI, Dawoud IE, 
Rashad FM. Isolation of probi-
otic lactobacilli strains harbor-
ing l-asparaginase and arginine 
deiminase genes from human 
infant feces for their potential 
application in cancer preven-
tion. Ann Microbiol. 2012 
2012/11/16/;63(3):1121-9. 
DOI: 10.1007/s13213-012-
0569-6. 
43. Mego M, Koncekova R, Mikus-
kova E, Drgona L, Ebringer L, 
Demitrovicova L, Nemova I, 
Trupl J, Mardiak J, Koza I, 
Zajac V. Prevention of febrile 
neutropenia in cancer patients 
by probiotic strain Enterococ-
cus faecium M-74. Phase II 
study. Support Care Cancer. 
2006 2006/03//;14(3):285-90. 
DOI: 10.1007/s00520-005-
0891-7. 
. 
 
Running Title: Cancer Prevention by Synbiotics Effect... 
Vol 1, Issue 1, Oct., 2015, p:26-38 
www.thecancerpress.com 
Sadeghi et al, 2015 
Bacterial translocation via intestinal mucosa is a significant mechanism of febrile neutropenia development. 
Competitive inhibition of bowel colonization by pathogenic microorganisms by probiotic LAB could be a use-
ful prevention of febrile neutropenia. Results demonstrated the safety of the probiotic strain Enterococcus faeci-
um M-74 enriched with selenium in leukemic patients with severe neutropenia. However, its administration was 
not effective in the prevention of febrile neutropenia, but this does not preclude the protective effect of other 
probiotic bacteria. An open pilot study carried out by Boutron-Ruault et al. (44) evaluated the influence of short
-chain fructo-oligosaccharides on parameters that are indicative of colon cancer in adenoma and adenoma free 
patients. Interestingly, butyrate concentrations were lower in the adenoma patients compared to the adenoma 
free patients, although FOS supplementation significantly elevated the butyrate concentrations in ademona pa-
tients. Supplementation in adenoma free patients decreased the fecal lithocholic acid whilst cholic acid, ursode-
oxycholic acid and total bile acids were all significantly increased. The lack of significant effects in adenoma 
patients would indicate that FOS supplementation may have a role in the prevention of cancer in healthy hu-
mans.  New options are given through the genetic manipulation of probiotic LAB, designed to act as a delivery 
system for anti-cancer factors. Studies in vitro systems and in a wide range of animal models also provide con-
siderable evidence that probiotic bacteria, prebiotic ingredients and synbiotics exert anti-cancer effects. Their 
consumption may be beneficial in preventing the onset of cancer, but also in the treatment of existing tumors. 
However, evidence from human studies is still limited. Many researchers have pointed out the need for careful-
ly designed human clinical trials. Furthermore, research is required to identify the probiotics, prebiotics or syn-
biotics combination that will be more effective for humans. 
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Conclusion:  
Fiber-rich sourdough fermentation usually consists of synbiotic combinations of probiotic lactobacilli 
starters and prebiotic dietary fibers. Recently the potential of sourdough LAB to release anti-tumour pep-
tide during fermentation of cereal and nonconventional flours was confirmed. Furthermore, new bioactive 
compounds such as prebiotic oligosaccharides or other metabolites can be formed in cereal fermentations 
by sourdough. It is clear that probiotic, prebiotic and synbiotics hold great potential as a new strategy for 
the prevention and treatment of cancer. Fiber-rich sourdough fermentation as future food with ancient his-
tory, harboring synbiotic potentials for using as anti-cancer, too.     
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